Combined chemo-radiation extends survival in patients with anaplastic oligodendroglial tumours

Intermittent hormonal therapy less effective than continuous therapy when treating advanced prostate cancer

Lower-income Patients are less likely to participate in clinical trials

Bendamustine regimen more effective for lymphoma than standard CHOP

Early results from new PD-1 targeted immune therapy

New study asks patients preference on kidney cancer treatment

Relapse and survival of adolescent and young adult leukaemia patients

Adding bevacizumab to chemotherapy for platinum-resistant ovarian cancer improves progression-free survival

The Institute of Cancer Policy

The OECI and EurocanPlatform

Problems in the structure of clinical trials

Transfer of information through EurocanPlatform